Jove
Visualize
Contact Us

Related Experiment Videos

Noninvasive methods to study drug distribution.

Ruediger E Port1, Walter Wolf

  • 1German Cancer Research Center, E120, D-69009 Heidelberg, Germany. r.port@dkfz.de

Investigational New Drugs
|August 2, 2003
PubMed
Summary

Nuclear magnetic resonance spectroscopy (MRS) and dynamic contrast-enhanced magnetic resonance imaging (dMRI) noninvasively track drug distribution and metabolism in tissues. These techniques are crucial for understanding drug delivery to solid tumors and optimizing treatment strategies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Tracer kinetic modeling of a 14 kDa anti-CD8 PET tracer (2C8v144) for in vivo estimation of CD8 expression in tissue and blood, binding affinity, and total body receptor occupancy.

Journal of pharmacokinetics and pharmacodynamics·2026
Same author

Mixed-effects modeling of clinical DCE-MRI data: application to colorectal liver metastases treated with bevacizumab.

Journal of magnetic resonance imaging : JMRI·2014
Same author

The power of FDG-PET to detect treatment effects is increased by glucose correction using a Michaelis constant.

EJNMMI research·2012
Same author

18F-FDG PET as a surrogate biomarker in non-small cell lung cancer treated with erlotinib: newly identified lesions are more informative than standardized uptake value.

Journal of nuclear medicine : official publication, Society of Nuclear Medicine·2012
Same author

Quantitation of glucose uptake in tumors by dynamic FDG-PET has less glucose bias and lower variability when adjusted for partial saturation of glucose transport.

EJNMMI research·2012
Same author

Maximizing tumour exposure to anti-neuropilin-1 antibody requires saturation of non-tumour tissue antigenic sinks in mice.

British journal of pharmacology·2011
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Area of Science:

  • Pharmacokinetics and drug delivery research.
  • Noninvasive imaging techniques in biomedical research.

Background:

  • Positron emission tomography (PET), nuclear magnetic resonance spectroscopy (MRS), and dynamic contrast-enhanced magnetic resonance imaging (dMRI) are noninvasive methods for monitoring drug distribution in vivo.
  • Each technique offers unique advantages: PET quantifies radioactivity, MRS differentiates parent drugs from metabolites, and dMRI assesses physiological parameters relevant to drug distribution.

Purpose of the Study:

  • To highlight the utility of MRS and dMRI in studying tissue pharmacokinetics.
  • To demonstrate the application of these imaging techniques in evaluating drug behavior at target sites.
  • To underscore the potential of these methods in developing improved cancer treatment strategies.

Main Methods:

  • Utilizing MRS to measure concentrations of parent drugs and metabolites within specific tissue volumes.

Related Experiment Videos

  • Employing dMRI to assess physiological changes and contrast agent distribution at a pixel-by-pixel level.
  • Integrating pharmacokinetic data from MRS and dMRI to understand drug penetration, retention, and metabolism.
  • Main Results:

    • Successful application of MRS and dMRI in studies of tissue pharmacokinetics.
    • Demonstrated ability to evaluate drug amounts reaching and remaining at target tissues.
    • Provided insights into drug metabolism at the target site, particularly in solid malignant tumors.

    Conclusions:

    • MRS and dMRI are valuable tools for noninvasive pharmacokinetic studies.
    • These techniques offer critical information for optimizing drug delivery and treatment strategies for solid tumors.
    • Further research utilizing these methods can significantly advance therapeutic approaches.